Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes-Reply

被引：0
|
作者：
Ogawa, Eiichi [1 ]
Yeo, Yee Hui [2 ]
Nguyen, Mindie H. [3 ,4 ]
机构：
[1] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Japan
[2] Cedars Sinai Med Ctr, Div Gastroenterol & Hepatol, Los Angeles, CA USA
[3] Stanford Univ, Div Gastroenterol & Hepatol, Med Ctr, 750 Welch Rd,Ste 210, Palo Alto, CA 94304 USA
[4] Stanford Univ, Med Ctr, Dept Epidemiol & Populat Hlth, Palo Alto, CA 94304 USA
来源：
JAMA INTERNAL MEDICINE | 2023年 / 183卷 / 06期
关键词：
D O I：
10.1001/jamainternmed.2023.0557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：626 / 626
页数：1
相关论文
共 50 条
  • [31] Hepatitis C treatment with a direct-acting antiviral and concurrent carbamazepine: A case report
    Mah, Li Ean
    Rodda, Sheridan
    Flanagan, Eliza
    Braude, Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 113 - 113
  • [32] The effect of curing hepatitis C with direct-acting antiviral treatment on endothelial function
    Davis, Joshua S.
    Young, Melissa
    Lennox, Sandra
    Jones, Tracey
    Piero, Kim
    Pickles, Robert
    Oakley, Stephen
    ANTIVIRAL THERAPY, 2018, 23 (08) : 687 - 694
  • [33] Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
    Kanda, Tatsuo
    Nakamoto, Shingo
    Nakamura, Masato
    Jiang, Xia
    Miyamura, Tatsuo
    Wu, Shuang
    Yokosuka, Osamu
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (01) : 1 - 6
  • [34] Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy
    Cabezas, Joaquin
    Llerena, Susana
    Puente, Angela
    Fabrega, Emilio
    Crespo, Javier
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (07) : 421 - 430
  • [35] Hepatitis B Reactivation with Direct-Acting Antiviral Drugs for Hepatitis C
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1506): : 140 - 140
  • [36] Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients
    Cooper, Curtis L.
    Hatashita, Holly
    Corsi, Daniel J.
    Parmar, Parmvir
    Corrin, Raymond
    Garber, Gary
    ANNALS OF HEPATOLOGY, 2017, 16 (06) : 874 - 880
  • [37] Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients
    Hatashita, Holly
    Parmar, Parmvir
    Corsi, Daniel J.
    Cooper, Curtis
    HEPATOLOGY, 2016, 64 : 466A - 466A
  • [38] Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
    Leah L. Zullig
    Haresh L. Bhatia
    Ziad F. Gellad
    Mark Eatherly
    Rochelle Henderson
    Hayden B. Bosworth
    BMC Health Services Research, 19
  • [39] Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
    Zullig, Leah L.
    Bhatia, Haresh L.
    Gellad, Ziad F.
    Eatherly, Mark
    Henderson, Rochelle
    Bosworth, Hayden B.
    BMC HEALTH SERVICES RESEARCH, 2019, 19 (1)
  • [40] Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy
    Pillai, Anjana A.
    Anania, Frank A.
    Pearlman, Brian L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (12): : 1854 - 1856
12345